Adjuvant Radiation Therapy With Ifosfamide in Patients With Mixed Mesodermal Tumors of the Uterus

NCT00231842 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Uterine Cancer

Interventions

DRUG: Ifosfamide
DEVICE: Radiation Therapy
DRUG: Cisplatin

Sponsor

Montefiore Medical Center